Loading
Total declarations
Companies
▲ Purchases (8 ops.)
▼ Sales (25 ops.)
Latest filing published 22 Jan 2015 for Streamline Health Solutions INC., €76k.
Insider track record
Disclosed buys
8
Disclosed sells
25
Signal history
No signal scores available.
Closed purchases
Market purchases
8
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Andrew L. Turner: trading record in brief
Andrew L. Turner has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Watson Pharmaceuticals Inc, Streamline Health Solutions Inc. and Allergan plc. Over a trading history stretching from 5 May 2006 to 17 March 2015, the count stands at 57 filings.
On the open market, the record shows 8 purchases worth €82k and 25 sales worth €3.5M. Sales outweigh purchases by €3.5M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 20 share grants and 3 option exercises. In 2015 alone, the filings show no purchases and 1 sale.
In size, the median ticket on the buying side is €6,442.
The latest filing, published on 19 March 2015, reports a share grant of €160k in Allergan plc. The last purchase on record was published on 30 December 2011, which is 5,412 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Andrew L. Turner
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations51 total
24,960 shares@ US$3.54Common Stock, $.01 par valueSEC:0001209191-15-005934:0
17,567 shares@ US$3.83Common Stock, $.01 par valueSEC:0001209191-14-059743:0
9,153 shares0Common Stock $.01 Par ValueSEC:0001209191-14-053812:0
12,500 shares@ US$6.71Common Stock $.01 Par ValueSEC:0001209191-13-058796:0
12,500 shares@ US$6.55Common Stock $.01 Par ValueSEC:0001209191-13-058796:1
264 shares@ US$162.43Ordinary SharesSEC:0001179110-13-017610:0
2,500 shares@ US$163.45Ordinary SharesSEC:0001179110-13-017092:0
2,677 shares@ US$156.48Ordinary SharesSEC:0001179110-13-016239:0
5,441 sharesOrdinary SharesSEC:0001179110-13-015219:0
5,441 sharesCommon Stock, par value $0.0033SEC:0001179110-13-015067:0
1,877 shares0Common Stock, par value $0.0033SEC:0001179110-13-008362:0
2,500 shares@ US$85.76Common Stock, par value $0.0033SEC:0001179110-13-004077:0
21,391 shares@ US$1.94Common Stock $.01 Par ValueSEC:0001209191-12-031369:0
20,000 shares@ US$36.80Common Stock, par value $0.0033SEC:0001179110-12-009305:0
20,000 shares@ US$73.59Common Stock, par value $0.0033SEC:0001179110-12-009305:1
2,887 shares0Common Stock, par value $0.0033SEC:0001179110-12-008409:0
1,592 shares@ US$1.57Common Stock $.01 Par ValueSEC:0001209191-12-000991:0
30,303 shares@ US$1.65Common Stock $.01 Par ValueSEC:0001209191-11-063507:0
Canonical exit: 27 Mar 2012 (T+90)
10,000 shares@ US$36.80Common Stock, par value $0.0033SEC:0001179110-11-015206:0
10,000 shares@ US$65.76Common Stock, par value $0.0033SEC:0001179110-11-015206:1
4,000 shares@ US$65.90Common Stock, par value $0.0033SEC:0001179110-11-013260:0
1,000 shares@ US$64.75Common Stock, par value $0.0033SEC:0001179110-11-012208:0
14,480 shares@ US$1.68Common Stock $.01 Par ValueSEC:0001209191-11-031180:0
3,177 shares0Common Stock, par value $0.0033SEC:0001179110-11-008145:0
5,000 shares@ US$42.58Common Stock, par value $0.0033SEC:0001179110-10-010405:0
25 of 51 declarations
